Vice Provost and Dean of Research
Showing 361-380 of 2,456 Results
-
Joonhee Choi
Assistant Professor of Electrical Engineering
BioJoonhee Choi is an Assistant Professor of Electrical Engineering at Stanford University. Joonhee received his Ph.D. and master’s from Harvard University, as well as master’s and bachelor’s degrees from Korea Advanced Institute of Science & Technology. Prior to joining Stanford, he worked as an IQIM postdoctoral fellow at the Institute for Quantum Information and Matter (IQIM) at Caltech. Joonhee’s research focus has been on engineering the dynamics of quantum many-body systems for both exploring fundamental science and demonstrating practical quantum applications. Throughout his career, he has worked in a wide variety of fields, including nonlinear nano-optics, ultrafast phenomena, solid-state and atomic physics, as well as quantum many-body physics. His expertise extends to practical applications in quantum metrology, communication, and information processing.
-
Yejin Choi
Dieter Schwarz Foundation HAI Professor and Senior Fellow at the Stanford Institute for Human-Centered Artificial Intelligence
BioYejin Choi is the Dieter Schwarz Foundation Professor and Senior Fellow at the Department of Computer Science at Stanford University and the Stanford Institute for Human-Centered Artificial Intelligence (HAI) respectively. Choi is MacArthur Fellow (class of 2022), AI2050 Senior Fellow (class of 2024), and named among Time100 Most Influential People in AI in 2023. In addition, Choi is a co-recipient of 2 Test-of-Time awards and 8 Best and Outstanding Paper Awards at top AI conferences including ACL, ICML, NeurIPS, ICCV, CVPR, and AAAI, the Borg Early Career Award (BECA) in 2018, the inaugural Alexa Prize Challenge in 2017, and IEEE AI’s 10 to Watch in 2016. Choi was a main stage speaker at TED 2023, and a keynote speaker for a dozen conferences across several AI disciplines including ACL, CVPR, ICLR, MLSys, VLDB, WebConf, and AAAI. Her current research interests include fundamental limits and capabilities of large language models, alternative training recipes for language models, symbolic methods for neural networks, reasoning and knowledge discovery, moral norms and values, pluralistic alignment, and AI safety.
-
Danny Hung-Chieh Chou
Associate Professor of Pediatrics (Endocrinology) and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur research program integrates concepts of chemical biology, protein engineering and structure biology to design new therapeutic leads and generate probes to study biological processes. A key focus of our lab is insulin, an essential hormone in our body to reduce blood glucose levels. We generate synthetic libraries of insulin analogs to select for chemical probes, and investigate natural insulin molecules (e.g. from the venom of fish-hunting cone snails!) to develop novel therapeutic candidates. We are especially interested in using chemical and enzymatic synthesis to create novel chemical entities with enhanced properties, and leverage the strong expertise of our collaborators to apply our skill sets in the fields of cancer biology, immunology and pain research. Our ultimate goal is to translate our discovery into therapeutic interventions in human diseases.
-
Angele Christin
Associate Professor of Communication, by courtesy, of Sociology and Senior Fellow at the Stanford Institute for Human-Centered AI
Current Research and Scholarly InterestsAngèle Christin studies the social and cultural impact of algorithms and artificial intelligence.
Her award-winning book, Metrics at Work: Journalism and the Contested Meaning of Algorithms (Princeton University Press, 2020) examined the dramatic transformations of journalism with the rise of social media platforms, metrics, and algorithms. Drawing on ethnographic methods, Angèle compared how American and French journalists made sense of traffic numbers, which in turn came with distinct effects on the production of news in the two countries.
Her most recent project examines the paradoxes of algorithmic labor through a study of influencers and influencer marketing on YouTube, Instagram, and TikTok. -
Constance Chu, MD
Professor of Orthopaedic Surgery (Sports Medicine)
BioDr. Constance R. Chu is Professor and Vice Chair Research, in the Department of Orthopedic Surgery at Stanford University. She is also Director of the Joint Preservation Center and Chief of Sports Medicine at the VA Palo Alto. Previously, she was the Albert Ferguson Endowed Chair and Professor of Orthopaedic Surgery at the University of Pittsburgh. She is a clinician-scientist who is both principal investigator of several projects funded by the National Institutes of Health and who has been recognized as a Castle-Connelly/US News and World Report “Top Doctor” in Orthopedic Surgery as well as on Becker’s list of Top Knee Surgeons in the United States. Her clinical practice focuses on the knee: primarily restoration and reconstruction of the ACL, menisci and cartilage. She graduated from the U.S. Military Academy at West Point and earned her medical degree from Harvard Medical School.
As Director of the multi-disciplinary Joint Preservation Center structured to seamlessly integrate the latest advances in biologics, mechanics, and imaging with comprehensive patient centered musculoskeletal and orthopedic care, Dr. Chu aims to develop a new model for health care delivery, research and education with an emphasis on health promotion and prevention. Cornerstones of this program include teamwork and a focus on personalized medicine. A central goal is to transform the clinical approach to osteoarthritis from palliation to prevention. In addition to optimizing clinical operations, outstanding research is critical to developing more effective new treatments. Towards this end, Dr. Chu is leading innovative translational research from bench to bedside in three main areas: quantitative imaging and biomarker development for early diagnosis and staging of joint and cartilage injury and degeneration; cartilage tissue engineering and stem cell based cartilage repair; and molecular and biological therapies for joint restoration and joint rejuvenation. Her research efforts have led to more than 30 professional awards and honors to include a Kappa Delta Award, considered to be the highest research honor in Orthopedic Surgery.
Dr. Chu also regularly holds leadership and committee positions in major professional organizations such as the American Association of Orthopedic Surgeons (AAOS) and the American Orthopedic Association (AOA). In her subspecialty of Orthopedic Sports Medicine, she is a past President of the Forum Sports Focus Group, a member of the Herodicus Society of leaders in Sports Medicine, and immediate past Chair of the American Orthopedic Society for Sports Medicine (AOSSM) Research Council. She is alumnus of the AOA American, British, Canadian (ABC) and the AOSSM Traveling Fellowships. -
Gilbert Chu
Professor of Medicine (Oncology) and of Biochemistry
Current Research and Scholarly InterestsAfter shuttering the wet lab, we have focused on: a point-of-care device to measure blood ammonia and prevent brain damage; a human protein complex that juxtaposes and joins DNA ends for repair and V(D)J recombination; and strategies for teaching students and for reducing selection bias in educational programs.
-
Lawrence Chu, MD, MS
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsI have two lines of research, one involving educational informatics and use of technology in postgraduate medical education and another involving NIH-funded work in patient-oriented clinical research regarding opioid use and physiologic responses associated with acute and chronic exposure in humans.
For a full description of my educational informatics work, please see my website aim.stanford.edu.
My clinical research focuses on the study opiate-induced hyperalgesia in patients suffering from chronic pain.
I am currently conducting an NIH-funded five year double-blinded randomized controlled clinical study (NIGMS award 1K23GM071400-01) that prospectively examines the following hypotheses: 1) pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) opiate-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) opiate-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity.
The study is the first quantitative and prospective examination of tolerance and hyperalgesia in pain patients and may have important implications for the rational use of opioids in the treatment of chronic pain. -
Steven Chu
William R. Kenan Jr. Professor, Professor of Molecular and Cellular Physiology and of Energy Science and Engineering
Current Research and Scholarly InterestsSynthesis, functionalization and applications of nanoparticle bioprobes for molecular cellular in vivo imaging in biology and biomedicine. Linear and nonlinear difference frequency mixing ultrasound imaging. Lithium metal-sulfur batteries, new approaches to electrochemical splitting of water. CO2 reduction, lithium extraction from salt water
-
Katrin Chua
Professor of Medicine (Endocrinology, Gerontology and Metabolism)
On Partial Leave from 02/01/2026 To 08/31/2026Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.
-
William Chueh
Director, Precourt Institute for Energy, Kimmelman Professor, Professor of Materials Science and Engineering, of Energy Science and Engineering, and Senior Fellow at the Precourt Institute for Energy
BioThe availability of low-cost but intermittent renewable electricity (e.g., derived from solar and wind) underscores the grand challenge to store and dispatch energy so that it is available when and where it is needed. Redox-active materials promise the efficient transformation between electrical, chemical, and thermal energy, and are at the heart of carbon-neutral energy cycles. Understanding design rules that govern materials chemistry and architecture holds the key towards rationally optimizing technologies such as batteries, fuel cells, electrolyzers, and novel thermodynamic cycles. Electrochemical and chemical reactions involved in these technologies span diverse length and time scales, ranging from Ångströms to meters and from picoseconds to years. As such, establishing a unified, predictive framework has been a major challenge. The central question unifying our research is: “can we understand and engineer redox reactions at the levels of electrons, ions, molecules, particles and devices using a bottom-up approach?” Our approach integrates novel synthesis, fabrication, characterization, modeling and analytics to understand molecular pathways and interfacial structure, and to bridge fundamentals to energy storage and conversion technologies by establishing new design rules.
-
Benjamin I. Chung
Professor of Urology and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsRenal cell carcinoma and prostate cancer outcomes research and epidemiology.
-
Karlene Cimprich
Professor of Chemical and Systems Biology and, by courtesy, of Biochemistry
On Partial Leave from 03/01/2026 To 04/30/2026Current Research and Scholarly InterestsGenomic instability contributes to many diseases, but it also underlies many natural processes. The Cimprich lab is focused on understanding how mammalian cells maintain genomic stability in the context of DNA replication stress and DNA damage. We are interested in the molecular mechanisms underlying the cellular response to replication stress and DNA damage as well as the links between DNA damage and replication stress to human disease.
-
Thomas J Cirino
Research Scientist, Animal Pharmacology, Innovative Medicines Accelerator (IMA)
BioIn Vivo Pharmacologist with expertise in CNS disorders including neurodegenerative disease, psychiatric disorders and pain.
-
Thomas Clandinin
Shooter Family Professor
Current Research and Scholarly InterestsThe Clandinin lab focuses on understanding how neuronal circuits assemble and function to perform specific computations and guide behavior. Taking advantage of a rich armamentarium of genetic tools available in the fruit fly, combined with imaging, physiology and analytical techniques drawn from systems neuroscience, we examine a variety of visual circuits.
-
Daniel Clark, MD, MPH
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor, Pediatrics - CardiologyBioDr. Clark is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. He is also a clinical assistant professor with dual appointments in the Division of Cardiovascular Medicine, Department of Medicine and the Division of Cardiology, Department of Pediatrics at Stanford University School of Medicine.
Dr. Clark specializes in the diagnosis and treatment of adult congenital heart disease (ACHD) and the management of congenital and acquired heart disease in children. His clinical focus involves the combined use of cardiac magnetic resonance (CMR) and other imaging techniques to evaluate patients with known or suspected cardiovascular disease. Dr. Clark’s extensive training and experience with these techniques include multiple fellowships in adult cardiology, cardiovascular imaging, and ACHD.
Dr. Clark is currently a co-investigator on multiple research studies. During his fellowship, he received a training grant from the National Institutes of Health enabling evaluation of the ability of CMR to diagnose COVID-19-associated heart inflammation among college athletes. He currently uses CMR to assess heart transplant outcomes in donors positive for hepatitis C virus. Dr. Clark also received a research grant from the Adult Congenital Heart Disease Association supporting a randomized, controlled clinical trial of cardiac rehabilitation among patients with Fontan failure.
Dr. Clark serves as a peer reviewer for multiple prestigious journals, including The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Journal of the American Heart Association (JAHA). He serves on the editorial board for both JAHA and Circulation: Cardiovascular Imaging. He is also a member of numerous professional medical societies, including the American College of Cardiology, the American Heart Association, and the Adult Congenital Heart Association.
